<DOC>
	<DOC>NCT01057030</DOC>
	<brief_summary>The purpose of this study is to assess the safety and tolerability of multiple oral daily doses of BMS-708163 in healthy young male subjects</brief_summary>
	<brief_title>Multiple Dose Japanese Bridging Study</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<criteria>Healthy Japanese and nonJapanese subjects Japanese subjects must be first generation Japanese and must demonstrate both maternal and paternal Japanese ancestry NonJapanese subjects must not be of Japanese or Asian descent, ie, neither parent nor grandparent was born in Japan or in any Asian country BMI of 19 to 25 kg/m², for Japanese and nonJapanese subjects Men ages 20 to 45 years Serum creatinine values above the normal range Urine protein or blood levels above the normal range Liver function tests above the normal range TSH, free T3, or free T4 outside the normal range Amylase or lipase levels above the normal range Positive Fecal Immunochemical Test (FIT™)</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>June 2010</verification_date>
</DOC>